The United States’ status as a country that has eliminated measles is under scrutiny, with a critical review of its elimination status delayed until November. While concerns arose that the postponement was politically motivated, the World Health Organization (WHO) maintains the decision stems from a demand for more comprehensive data analysis. This delay comes as the US grapples with a resurgence of measles cases, raising questions about vaccination rates and public health preparedness.
The review, initially scheduled for April 2026, is now set to occur after the US midterm elections. The Pan American Health Organization (PAHO), the WHO’s regional arm for the Americas, is leading the assessment, which could result in the US losing its “elimination status” – a designation achieved in 2000 after decades of effort to control the highly contagious disease. The WHO emphasizes that a thorough evaluation is paramount, ensuring all evidence is “scrupulously done,” according to Kate O’Brien, director of the Department of Immunization, Vaccines, and Biologicals at WHO.
Rising Cases and the Push for Data
The US has experienced a significant increase in measles outbreaks, particularly in Texas and South Carolina, with recent outbreaks exceeding 1,000 cases. Experts attribute this resurgence to declining vaccination rates and increased community transmission. The WHO routinely verifies elimination status annually, assessing whether a country has maintained the absence of sustained local measles transmission for at least 12 months. PAHO initially planned to review the US and Mexico’s status in April, but has since adjusted the timeline to allow for a more robust assessment.
“The meeting date has been set to give national health authorities and national sustainability committees sufficient time to prepare comprehensive reports, including descriptions and analyses with detailed epidemiological and laboratory evidence, for review by the Commission,” PAHO announced. O’Brien further explained that the typical timing for such reviews is in the fourth quarter of the year, allowing for a complete review of the year’s data. This ensures the external committee has all necessary information to make an informed decision.
Global Context and Declining Immunization
The US is not alone in facing challenges to measles elimination. In January 2026, several European and Central Asian nations – including the UK, Spain, Armenia, Azerbaijan, and Uzbekistan – lost their elimination status, highlighting a global trend. Historically, the Americas region has led the world in measles elimination, but outbreaks in the US, Canada, and Mexico threaten that standing. Globally, an estimated 95,000 measles deaths occur annually, primarily among unvaccinated or under-vaccinated children under the age of five, according to the WHO.
Slipping vaccination rates in higher-income countries are a key driver of this resurgence. In the last school year, 13 US states reported vaccination rates below 90%, a significant increase from the six states below that threshold in 2010, according to data from the Centers for Disease Control and Prevention (CDC). Only ten states currently meet the WHO’s recommended herd immunity threshold of 95%.
Vaccination has been remarkably effective in preventing measles, averting nearly 59 million deaths in the past quarter-century. However, the measles virus remains highly contagious, infecting the respiratory tract and potentially leading to severe complications. Symptoms include high fever, cough, runny nose, and a widespread rash, as outlined by the WHO.
What comes next will depend on the data presented to PAHO in November. The outcome of the review will have significant implications for public health policy and vaccination efforts in the US. Continued monitoring of measles cases and vaccination rates will be crucial in determining the future of measles elimination in the Americas.
Have your say: What steps do you believe are most important to address declining vaccination rates and protect communities from measles outbreaks? Share your thoughts in the comments below.
Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
